arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

Cavitation Technologies, Inc.

CVAT
— Price unavailable
Materials ·Agricultural Services ·USAgricultural Services
20 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
73
Health
Good
Bullish
auto_awesome

Analytical Summary

Cavitation Technologies, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —
Dividend Yield —
Revenue Growth -98.5% ↘
Op. Margin None
ROIC 201.9% ↗
FCF / Share $-0.00 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity -0.22
info Valuation on last close.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.00K
↓ -98.5% —
Net Income Profit after all expenses
$-1.40M
↓ -1142.5% —
Operating Margin Operating profit as % of sales
-486.2%
↓ -1613.0% —
FCF / Share Free cash flow per share
$-0.00
↑ +11.7% —
Long-Term Debt Long-term obligations
$150.00K
↑ +11.1% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
99
Financial Health ↓
56
Cash Quality ↓
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 20 years · 79 quarters